A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Clinical trial NCT02176681 · COMPLETED
Trial details
- NCT number
- NCT02176681
- Sponsor
- University Hospital, Strasbourg, France
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.